Key information about PHESGO to save, print, or take with you.
There are many organizations that support people with cancer and their families. Many of these organizations can refer you to local chapters.
Information for people living with cancer, as well as families, friends, and survivors.
This website is dedicated to providing reliable and current medical information about treatment options, symptoms, diagnosis, and prevention.
Support and information for people who are newly diagnosed, in treatment, years beyond treatment, or living with breast cancer.
A national, independent, nonprofit advocacy group that is dedicated to the concerns of women and men living with metastatic breast cancer.
A network of breast and other cancer survivors who want to share their experience with others.
Information for people living with cancer, families, friends, and survivors.
An organization dedicated to critical issues in young women with breast cancer.
This is a partial list of some cancer support organizations. They are not controlled by, endorsed by, or affiliated with Genentech, Inc. The list is meant for informational purposes only and is not intended to replace your healthcare professional’s medical advice. Ask your doctor or your healthcare team any questions you have about your cancer or treatment plan.
Call the Patient Resource Center for answers to your questions about PHESGO or other resources from Genentech.
1 (877) GENENTECH (1-877-436-3683)
Monday-Friday, 6am-5pm PST
This is not meant to replace the advice of your healthcare team.
PHESGO® (pertuzumab, trastuzumab, and hyaluronidase-zzxf) is a prescription medicine approved for use in combination with chemotherapy for:
PHESGO is a prescription medicine approved for use in combination with docetaxel in adults who have HER2-positive breast cancer that has spread to different parts of the body (metastatic) and who have not received anti-HER2 therapy or chemotherapy for metastatic breast cancer.
PHESGO may cause heart problems, including those without symptoms (such as reduced heart function) and those with symptoms (such as congestive heart failure).
Receiving PHESGO during pregnancy can result in the death of an unborn baby and birth defects.
PHESGO may cause serious lung problems.
The most common side effects of PHESGO when given with chemotherapy as part of an early breast cancer regimen are:
The most common side effects of PHESGO when given with docetaxel for treatment of breast cancer that has spread to other parts of the body (metastatic) are:
You are encouraged to report side effects to Genentech and the FDA. You may report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at 1-888-835-2555.
Talk to a healthcare professional for more information about the benefits and risks of PHESGO.
Please see full Prescribing Information for additional Important Safety Information, including most serious side effects.
If you cannot afford your medication, visit phesgo.com/financial-support for financial assistance information.
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.